Accessibility Menu
Stereotaxis logo

Stereotaxis

(NYSEMKT) STXS

Current Price$1.78
Market Cap$183.75M
Since IPO (2004)-97%
5 Year-76%
1 Year-18%
1 Month-2%

Stereotaxis Financials at a Glance

Market Cap

$183.75M

Revenue (TTM)

$31.20M

Net Income (TTM)

-$21.68M

EPS (TTM)

-$0.24

P/E Ratio

-7.70

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$1.78

Volume

590,981

Open

$1.87

Previous Close

$1.78

Daily Range

$1.77 - $1.88

52-Week Range

$1.70 - $3.59

Estimated Earnings Date

Aug 6, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stereotaxis

Industry

Healthcare Equipment and Supplies

Employees

131

CEO

David Leo Fischel, CFA, CAIA

Headquarters

Saint Louis, MO 63101, US

STXS Financials

Key Financial Metrics (TTM)

Gross Margin

54%

Operating Margin

-68%

Net Income Margin

-70%

Return on Equity

-156%

Return on Capital

-69%

Return on Assets

-40%

Earnings Yield

-12.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$183.75M

Shares Outstanding

97.74M

Volume

590.98K

Avg. Volume

418.57K

Financials (TTM)

Gross Profit

$17.07M

Operating Income

-$22.11M

EBITDA

-$20.56M

Operating Cash Flow

-$13.69M

Capital Expenditure

-$93.00K

Free Cash Flow

-$13.78M

Cash & ST Invst.

$13.42M

Total Debt

$5.44M

Stereotaxis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$6.29M

-15.8%

Gross Profit

$3.79M

-6.6%

Gross Margin

60.31%

N/A

Market Cap

$183.75M

N/A

Market Cap/Employee

$1.32M

N/A

Employees

139

N/A

Net Income

-$5.86M

-0.7%

EBITDA

-$4.79M

+13.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$9.34M

+97.3%

Accounts Receivable

$9.62M

+122.5%

Inventory

$10.50M

+7.0%

Long Term Debt

$4.62M

-12.5%

Short Term Debt

$662.00K

+12.6%

Return on Assets

-40.13%

N/A

Return on Invested Capital

-69.04%

N/A

Free Cash Flow

-$3.52M

-97.9%

Operating Cash Flow

-$3.44M

-93.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SMTISanara MedTech Inc.
$22.44+1.45%
ARCTArcturus Therapeutics Holdings Inc.
$7.30-9.20%
QTRXQuanterix Corporation
$3.30-13.16%
SGMTSagimet Biosciences Inc.
$6.76-4.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
KEELKeel Infrastructure
$5.13-0.13%
NIONio
$5.36-0.06%
SNAPSnap
$5.76-0.05%
SGOViShares Trust - iShares 0-3 Month Treasury Bond ETF
$100.45+0.00%

Questions About STXS

What is the current price of Stereotaxis?

Stereotaxis is trading at $1.78 per share.

What is the 52-week range for Stereotaxis?

Over the past 52 weeks, Stereotaxis has traded between $1.70 and $3.59.

How much debt does Stereotaxis have?

As of the most recent reporting period, Stereotaxis reported total debt of $5.28M.

How much cash does Stereotaxis have on hand?

Stereotaxis reported $14.62M in cash and cash equivalents in its most recent financial results.

What is Stereotaxis’s dividend yield?

Stereotaxis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.